Halomine, Inc.
Publicly observedIthaca, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Ithaca | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Halomine, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | FT1LJN4UPKJ3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: Novel, bio-inspired chloramine for infection eradication in chronic wounds
USD 348,150.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Aug 2025Publicly observed
NIH SBIR/STTR award: Novel, bio-inspired chloramine to treat cutaneous fungal infections without resistance generation potential
USD 299,435.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant5 Aug 2020Publicly observed
NIH SBIR/STTR award: Novel, low corrosion, bio-compatible disinfectant with biofilm and residual efficacy
USD 990,066.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant5 Aug 2020Publicly observed
NIH SBIR/STTR award: Novel, low corrosion, bio-compatible disinfectant with biofilm and residual efficacy
USD 991,808.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.